INTRODUCTION
Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems 1 . The two main types of genes that are recognized as playing a role in cancer are oncogenes and tumor suppressor genes. Aberrant methylation is a widespread phenomenon in cancer and may be among the earliest changes to occur during oncogenesis. One of the major ro les of DNA methylation in mammals is thought to be in control of gene regulation. This is because methylation within gene regulatory regions such as promoters and enhancers generally suppresses their function 2 . Several lines of ev idence suggest that the methyl group in some cases directly interferes with the binding of transcription factors that activate transcription. In an alternative process, Cp G-b inding domain (M BD) proteins bind to the methyl group and subsequently to chromatin remodeling proteins (such as histone deacetylases) to silence the gene by making it transcriptionally unavailable. Genes that are methylated tend to be packaged more tightly, which causes them to be silenced. Genes that are not methylated tend to exhib it looser packaging, which allo ws their expression 3 . Mutations in certain tumour suppressor genes are most often thought of in association with their inactivation during cancer initiation or progression; epigenetic alterations such as DNA methylation appear to be tightly linked to the sequential non-reversible events of normal tissue differentiation and organogenesis 4 .
Hence our objectives of the present study are to understand the lung cancer methylome wh ich leads to identification of genes involved in causing lung cancers. Among the genes identified, tumor suppressor genes involved in lung cancer and their methylation frequencies are keyed out in different types of lung cancers.
MATERIALS AND METHODS

Retrieval of Lung Cancer Genes Methyl ati on Frequencies Information using PubMeth
Pubmeth is an annotated and reviewed database of methylation in cancer. PubMeth can be queried using the web-interface at http://matrix.ugent.be/pubmeth/search.html in two ways, depending on the researcher's focus: Gene-related: in which cancer types (and subtypes) the genes of interest are reported to be methylated and Cancer-related: which genes are reported to be methylated in the cancer types/subtypes. The Cancer-centric query approach is opted for the retrieval of methylated genes involving in Lung cancer. This type of search is meant to get a quick overview of the genes that are reported in the methylation context in the cancer (sub) types of interest and in which frequency, to explore methylation in the cancer types of interest 5 .
KEGG / Kyoto Encyclopedia of Genes & Genomes Pathway Maps
The KEGG Pathway database is a collection of graphical diagrams (KEGG pathway maps) and associated text information (KEGG pathway entries) for metabolism, various other cellular processes, and human diseases 6 . The KEGG pathway map is a moleculalr interaction/reaction network diagram represented in terms of the KEGG Orthology (KO) groups, so that experimental evidence in specific organisms can be generalized to other organisms through genomic information. Each map is manually drawn with in-house software called KegSketch, which generates the KGM L+ file 7 .
ABS TRACT
The causes of cancer are due to mutations of key proteins involved in cell cycle regulation, DNA repair enzymes and in some cases inactivation of tumor suppressor genes leads to the growth of tumors. The expression rates of TSGs vary in different stages of cancer as well in various cases of cancers. The inhibitions of TSGs are due to methylation of the DNA.
In our present study, we found the genes which are methylated in different types of lung cancers and identified the methylation frequencies. Using the pubmeth database, we have identified the total number of genes undergoing methylation in the various lung cancers. From the total number of genes, we have identified the tumor suppressor genes which are in the methylated state leading to the inactivation of expression and promoting the tumor growth. The further focus on tumor suppressor genes which are methylated is necessary to find a novel way to activate them in the cancerous stage. 
Methyl ati on Frequencies of TS Gs in Lung Cancer
In different types of lung cancers, it has been observed that no TSGs are likely having the same methylation frequencies / status. In each type of lung cancer different TSGs have different methylation status and these methylation statuses differ for various kinds of cancers also. The identified TSGs are tabulated in the 
KEGG -NSCLC & S CLC Pathway Maps
The identificat ion of TSGs in the cancer pathway maps gives an insight to the connectivity of other genes as well associative cellular mechanisms can be understood well. By the pathways, the ability to find the connectivity to other cellular pathways such as apoptosis, cell-cycle progression, etc can be graphically depicted. 
CONCLUS ION
By the PubMeth database studies, we can conclude that the minimu m nu mbers of genes in lung cancer cell lines involved in methylation are 44 genes. Among these 44 genes, 10 are identified as Tumor Suppressor Genes, and their detailed annotated information has been obtained through Genecards database. The 10 specific TSGs having different methylation frequencies have been observed. This indicates that methylation states are varied fro m one cancer to another type of cancer. The pathway maps focus the colligation of other genes and exploring differential gene connectivity and pathway conservation in identifying the novel ways to activate the tumor suppressor genes .
